MDEChem Analysis

MDEChem Pink Sheet Analysis Notes

The company had not issued any dividends in recent years. MDEChem had 3:1 split on the 7th of February 2000. MDEChem, Inc. provides pharmaceutical and chemical products. The company was founded in 1996 and is based in Floresville, Texas. Mdechem operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.The quote for MDEChem is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about MDEChem contact the company at 830-393-5293 or learn more at https://www.mdechem.com.

MDEChem Investment Alerts

MDEChem Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.1 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MDEChem's market, we take the total number of its shares issued and multiply it by MDEChem's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

MDEChem Profitablity

The company has Profit Margin (PM) of 0.46 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.52 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.52.

MDEChem Debt to Cash Allocation

The company has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist MDEChem until it has trouble settling it off, either with new capital or with free cash flow. So, MDEChem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MDEChem sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MDEChem to invest in growth at high rates of return. When we think about MDEChem's use of debt, we should always consider it together with cash and equity.

MDEChem Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the MDEChem's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of MDEChem, which in turn will lower the firm's financial flexibility.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

If you are still planning to invest in MDEChem check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MDEChem's history and understand the potential risks before investing.